Argan director exercises options, receives 895 shares
Net settlement resulted in 895 common shares, while 5,775 directly held common shares were reported afterward.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ARGAN INC (AGX) director Peter W. Getsinger exercised an option covering 1,000 shares on September 22, 2026, at $40.15 per share using net settlement, acquiring 895 common shares. Afterward, he reported 5,775 directly held common shares and options covering 2,000 shares. He also reported 133 shares held in a custody account for a child and 267 shares held in a children's trust. No Rule 10b5-1 plan is reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Option to Purchase Common Stock F1 | 1,000 | $40.15 | $40K |
| Exercise | Common Stock F1 | 895 | $40.15 | $36K |
| Holding | Common Stock | -- | -- | -- |
| Holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. On September 22, 2026, the Reporting Person exercised a portion of his stock option awarded on December 23, 2019 to purchase 1,000 shares of the Issuer's common stock at a price of $40.15 per share using the net settle method.
Key Figures
Key Terms
net settle method financial
stock option financial
Option to Purchase Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What AGX holdings did Peter W. Getsinger report after exercising options?
AI-generated analysis. How Rhea-AI works. Not financial advice.